Supplementary table 1 - Questions in the survey

In June 2023, patients with AD were interviewed about their treatment preferences for AD, includ-ing characteristics such as onset of action, side effects, and preferred administration route. Participants were asked various questions regarding treatment preferences and were instructed to select the statement they found most accurate.2023年6月，研究团队对阿尔茨海默病（AD）患者开展访谈，调研其针对AD的治疗偏好，涵盖起效时间、不良反应及首选给药途径等特征。研究人员向参与者提出一系列与治疗偏好相关的问题，并要求其选择最符合自身认知的表述。